Novogen Pharma

Novogen Pharma is a prominent pharmaceutical company based in Egypt and the United Arab Emirates, specializing in the development and marketing of branded generic medicines and nutritional supplements. The company has established a leading position in the Middle Eastern market, particularly within the orthopedic and rheumatology therapeutic areas. Its flagship product, Genuphil, is a widely recognized treatment for osteoarthritis and joint health in the MENA region. Novogen Pharma emphasizes quality and affordability, utilizing advanced manufacturing technologies to serve a diverse patient population. The company continues to expand its portfolio into pediatrics and internal medicine to address unmet healthcare needs. With a robust distribution network, Novogen Pharma remains a key player in the regional healthcare landscape.